Wealth Enhancement Advisory Services, LLC Pfizer Inc Transaction History

Wealth Enhancement Advisory Services, LLC

$49 Billion
Q1 2025

A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 2,606,123 shares of PFE stock, worth $62.5 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

2,606,123

Previous 1,676,443 55.46%

Holding current value

$62.5 Million

Previous $44.5 Million 48.48%

% of portfolio

0.13%

Previous 0.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 16, 2025	BUY	$25.01 - $27.13 $23.3 Million - $25.2 Million	929,680 Added 55.46%	2,606,123 $66 Million
Q4 2024 Mar 17, 2025	BUY	$24.8 - $30.19 $3.58 Million - $4.36 Million	144,334 Added 9.42%	1,676,443 $44.5 Million
Q4 2024 Jan 10, 2025	BUY	$24.8 - $30.19 $186,768 - $227,360	7,531 Added 0.49%	1,532,109 $40.6 Million
Q3 2024 Oct 23, 2024	SELL	$27.7 - $31.39 $3.44 Million - $3.9 Million	-124,233 Reduced 7.53%	1,524,578 $44.1 Million
Q2 2024 Jul 16, 2024	BUY	$25.26 - $29.6 $554,962 - $650,312	21,970 Added 1.35%	1,648,811 $46.1 Million
Q1 2024 Apr 15, 2024	SELL	$25.89 - $29.73 $5.34 Million - $6.13 Million	-206,117 Reduced 11.25%	1,626,841 $45.1 Million
Q4 2023 Jan 30, 2024	BUY	$26.13 - $33.94 $1.46 Million - $1.89 Million	55,819 Added 3.14%	1,832,958 $52.8 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $47.3 Million - $55.3 Million	1,474,649 Added 487.5%	1,777,139 $58.9 Million
Q2 2023 Jul 21, 2023	SELL	$36.12 - $41.79 $107,529 - $124,408	-2,977 Reduced 0.97%	302,490 $11.1 Million
Q1 2023 Apr 25, 2023	BUY	$39.39 - $51.28 $3.95 Million - $5.14 Million	100,281 Added 48.87%	305,467 $12.5 Million
Q4 2022 Feb 01, 2023	BUY	$41.75 - $54.5 $3.02 Million - $3.94 Million	72,375 Added 54.49%	205,186 $10.5 Million
Q3 2022 Oct 17, 2022	SELL	$43.76 - $53.42 $416,113 - $507,970	-9,509 Reduced 6.68%	132,811 $5.62 Million
Q2 2022 Jul 18, 2022	BUY	$46.53 - $55.17 $3.67 Million - $4.36 Million	78,953 Added 124.6%	142,320 $7.57 Million
Q1 2022 Apr 18, 2022	SELL	$45.75 - $56.69 $107,924 - $133,731	-2,359 Reduced 3.59%	63,367 $3.23 Million
Q4 2021 Feb 08, 2022	BUY	$41.32 - $61.25 $2.11 Million - $3.12 Million	50,944 Added 344.64%	65,726 $3.46 Million
Q3 2021 Nov 03, 2021	SELL	$39.25 - $50.42 $2.02 Million - $2.6 Million	-51,508 Reduced 77.7%	14,782 $644,000
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $1.86 Million - $2.1 Million	51,686 Added 353.92%	66,290 $2.66 Million
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $489,087 - $551,593	14,604 New	14,604 $526,000
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $4.3 Million - $5.05 Million	-135,494 Closed	0 $0
Q2 2020 Oct 13, 2020	BUY	$30.12 - $36.54 $4.08 Million - $4.95 Million	135,494 New	135,494 $5.23 Million
Q1 2020 May 01, 2020	SELL	$27.03 - $38.62 $140,258 - $200,399	-5,189 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$32.92 - $37.36 $1.92 Million - $2.17 Million	-58,208 Reduced 91.82%	5,189 $203,000
Q3 2019 Nov 06, 2019	BUY	$32.49 - $42.13 $151,143 - $195,988	4,652 Added 7.92%	63,397 $2.29 Million
Q2 2019 Aug 02, 2019	SELL	$36.98 - $41.52 $1.27 Million - $1.42 Million	-34,301 Reduced 36.86%	58,745 $2.44 Million
Q1 2019 Apr 30, 2019	SELL	$37.5 - $41.2 $346,012 - $380,152	-9,227 Reduced 9.02%	93,046 $3.67 Million
Q4 2018 Feb 04, 2019	BUY	$38.47 - $43.86 $3.93 Million - $4.49 Million	102,273 New	102,273 $4.35 Million
Q2 2018 Jul 30, 2018	SELL	$32.98 - $35.16 $3.84 Million - $4.1 Million	-116,571 Closed	0 $0
Q1 2018 Apr 26, 2018	BUY	$31.91 - $37.02 $1.87 Million - $2.17 Million	58,711 Added 101.47%	116,571 $4.24 Million
Q4 2017 Jan 19, 2018	BUY	$33.26 - $35.29 $1.92 Million - $2.04 Million	57,860	57,860 $2.11 Million

Others Institutions Holding PFE

# of Institutions

3,368

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $135B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.

Account

Wealth Enhancement Advisory Services, LLC Pfizer Inc Transaction History